NMS公司近日在提交给美国证券交易委员会(SEC)的文件中指控,Cardiff Oncology, Inc. 违反了双方就Cardiff相关专利发明权所达成的协议。这一争议涉及关键知识产权的归属问题,可能对公司的业务前景产生影响。
NMS公司近日在提交给美国证券交易委员会(SEC)的文件中指控,Cardiff Oncology, Inc. 违反了双方就Cardiff相关专利发明权所达成的协议。这一争议涉及关键知识产权的归属问题,可能对公司的业务前景产生影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.